HIF1A and prostate cancer: The KEGG pathway enrichment analysis showed that EGFR tyrosine kinase inhibitor resistance, endocrine resistance, pancreatic cancer, prostate cancer, the HIF-1 signaling pathway, and proteoglycans in cancer and other pathways may be potential signaling pathways for the treatment of UTIs with SJT.